Clinical Trials Browser

Suspended × N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine × Clear all

NCT00591682 2008-03-26

MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

Phase 1 Suspended

Other solid neoplasm

Solid Tumors